News
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
4d
Everyday Health on MSNCan GLP-1 Patches Really Help You Lose Weight?
Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...
The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...
The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.
56m
Health and Me on MSNWeight Loss Drugs For Dementia – Study Finds It May Prevent Cognitive As Well As Cardiovascular Issues
As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ensure safety. One such research has shown that it could help prevent cognitive ...
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.
11d
Health and Me on MSNGLP-1 Weight Loss Drug Effectiveness Increases With This Therapy In Postmenopausal Women: Study
Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results